JP6945614B2 - 経鼻投与 - Google Patents

経鼻投与 Download PDF

Info

Publication number
JP6945614B2
JP6945614B2 JP2019230957A JP2019230957A JP6945614B2 JP 6945614 B2 JP6945614 B2 JP 6945614B2 JP 2019230957 A JP2019230957 A JP 2019230957A JP 2019230957 A JP2019230957 A JP 2019230957A JP 6945614 B2 JP6945614 B2 JP 6945614B2
Authority
JP
Japan
Prior art keywords
nasal
sumatriptan
administration
therapeutic agent
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019230957A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020073510A5 (cg-RX-API-DMAC7.html
JP2020073510A (ja
Inventor
ギスレ ジュペスランド，パー
ギスレ ジュペスランド，パー
マハムード，ラミー，エイ．
メッシーナ，ジョン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Optinose AS
Original Assignee
Optinose AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2016504771A external-priority patent/JP6675974B2/ja
Application filed by Optinose AS filed Critical Optinose AS
Priority to JP2019230957A priority Critical patent/JP6945614B2/ja
Publication of JP2020073510A publication Critical patent/JP2020073510A/ja
Publication of JP2020073510A5 publication Critical patent/JP2020073510A5/ja
Application granted granted Critical
Publication of JP6945614B2 publication Critical patent/JP6945614B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2019230957A 2014-03-26 2019-12-20 経鼻投与 Active JP6945614B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019230957A JP6945614B2 (ja) 2014-03-26 2019-12-20 経鼻投与

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016504771A JP6675974B2 (ja) 2013-03-26 2014-03-26 経鼻投与
JP2019230957A JP6945614B2 (ja) 2014-03-26 2019-12-20 経鼻投与

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016504771A Division JP6675974B2 (ja) 2013-03-26 2014-03-26 経鼻投与

Publications (3)

Publication Number Publication Date
JP2020073510A JP2020073510A (ja) 2020-05-14
JP2020073510A5 JP2020073510A5 (cg-RX-API-DMAC7.html) 2020-09-10
JP6945614B2 true JP6945614B2 (ja) 2021-10-06

Family

ID=70609984

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019230957A Active JP6945614B2 (ja) 2014-03-26 2019-12-20 経鼻投与

Country Status (1)

Country Link
JP (1) JP6945614B2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118236612B (zh) * 2024-03-26 2024-12-17 苏州新劢德医疗器械科技有限公司 一种递送流体到用户鼻气道的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416884D0 (en) * 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
PT1218049E (pt) * 1999-07-12 2007-01-31 Capnia Inc Aparelho para o alívio de dores de cabeça, rinite e outros padecimentos comuns
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
GB0602980D0 (en) * 2006-02-14 2006-03-29 Optinose As Delivery device and method
EP2116264B1 (en) * 2006-12-26 2017-09-27 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
CA2698683A1 (en) * 2007-09-07 2009-03-12 Epigenesis Pharmaceuticals, Llc Dheas inhalation compositions
MX2011000590A (es) * 2008-07-15 2011-03-01 Schering Corp Composiciones intranasales que comprenden un descongestionante y un corticosteroide.
CN103269687B (zh) * 2011-01-04 2016-09-14 伊斯塔制药公司 贝托斯汀组合物
BR112014020260A8 (pt) * 2012-02-16 2017-07-11 Capnia Inc Distribuidor de gás com peça nasal de difusão
BR112015024869A8 (pt) * 2013-03-26 2019-12-17 Optinose As uso de um agente terapêutico e/ou de diôxido de carbono para tratar um paciente e aparelhos e métodos para tratar terapeuticamente um paciente

Also Published As

Publication number Publication date
JP2020073510A (ja) 2020-05-14

Similar Documents

Publication Publication Date Title
US20250339632A1 (en) Nasal administration
JP6675974B2 (ja) 経鼻投与
JP7090124B2 (ja) 経鼻投与
US11278682B2 (en) Device and method for aerosolized delivery of substance to a natural orifice of the body
US20200306463A1 (en) Drug delivery devices and methods for administering substances to a body cavity by heterogenous aerosolization for treatment of binge-eating disorders andor obesity
CN112912124A (zh) 用于向身体的自然腔道雾化递送物质的装置和方法
WO2021245605A1 (en) Drug delivery devices and methods for administering substances to a body cavity by heterogenous aerosolization for treatment of binge-eating disorders and/or obesity
US20230158259A1 (en) Products of manufacture and methods for treating, ameliorating or preventing microbial infections
JP6945614B2 (ja) 経鼻投与
CA2908232C (en) Nasal administration of fluticasone and carbon dioxide
HK1221672B (en) Nasal administration
PARDESHI et al. Indian Journal of Novel Drug Delivery

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200730

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201208

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210112

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210114

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210608

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210817

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210914

R150 Certificate of patent or registration of utility model

Ref document number: 6945614

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250